| Frasch, Markus (AppliChem 200904 Managing Director) |
Managing Director |
Illinois Tool Works (ITW) (Group) |
Germany |
| Fraser, Paul D. (Univ London 201403 Professor at Royal Holloway and Bedford New College) |
Professor |
University of London |
United Kingdom (GB) |
| Frauendorf, Holm (Univ Göttingen 200910 Head Div Zentrale Analytik) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Göttingen (Georg August University) |
Germany |
| Frearson, Julie (Charles River 201711 Corp VP Global Discovery Services) |
President/Director/Head Business Group/Unit/Division |
Charles River (Group) |
United States (USA) |
| Frech, Kornelie (Genomatix 200608 Head of Biological Databases) |
n. a. |
Genomatix Software (Group) |
Germany |
| Fréchet, Jean M. J. (KAUST 201803 Prof + SVP Research + Innovation + Economic Development) |
Professor |
King Abdullah University of Science and Technology (KAUST) |
Saudi Arabia |
| Freedman, Stephen (Gladstone Institutes 201507 VP Corporate Liaison + Ventures) |
Business Development Manager / Strategy Manager |
Gladstone Institutes (Group) |
United States (USA) |
| Freeman, David M. (Cell Signaling Technology 201301 Head of Global Marketing) |
Sales Manager / Marketing Manager |
Cell Signaling Technology (CST) (Group) |
United States (USA) |
| Fregien, Jörg (Life Science Inkubator 201103 Managing Director) |
Managing Director |
Life Science Inkubator GmbH (LSI) |
Germany |
| Frei, Patrik (Venture Valuation 201802 CEO + Founder) |
Chief Executive Officer (CEO) |
Venture Valuation (Group) |
Switzerland |
| Freier, Gottfried W. (Kaye Scholer LLP 200809 Frankfurt/M) |
Attorney / Lawyer |
Arnold & Porter LLP |
Germany |
| Freischem, Barbara (EBE 201609 Executive Director) |
lobbying |
EFPIA (European Federation of Pharmaceutical Industries Associations) |
Belgium |
| Freitag, Chris (Dynacure 201807– CMO before Debioparm + BTG plc + Shire + Roche) |
Chief Medical Officer (CMO) |
Dynacure S.A.S. |
France |
| French, Hayley (Apitope 201810– COO + interim CEO before CBO + General Counsel since 11/10 before Novartis) |
Chief Operating Officer (COO) |
Apitope (Group) |
Belgium |
| Frenzel, Bernd (Biochrom AG 201110 CEO) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
Germany |
| Freudenberg, Rainer (CMS 201408 Associate at CMS Hasche Sigle Ffm) |
Attorney / Lawyer |
CMS (Group) |
Germany |
| Frey, Olivier (InSphero 2016– Microphysiological Systems Product Manager before ETHZ) |
Product Manager (personnel) |
InSphero (Group) |
Switzerland |
| Freyberg, Mark-Andre (CytoTools 201111 Managing Director) |
Managing Director |
CytoTools (Group) |
Germany |
| Freyer, Ralf (Polyplan GmbH 200902 Managing Director) |
Managing Director |
Polyplan (Group) |
Germany |
| Fricke, Harald (Apogenix GmbH 200511– CMO + COO before Fresenius Biotech + Baxter + GSK) |
Chief Medical Officer (CMO) |
Apogenix GmbH |
Germany |
| Frickel, Fritz (Therascope 200307 CEO) |
Chief Executive Officer (CEO) |
Amgen (Group) |
Germany |
| Friebe, Margaret (m2f Investment Ltd 201305 Managing Director) |
Investment Manager |
m2f Investment Ltd. (DE) |
Germany |
| Friebe, Michael (m2f Investment Ltd 201305 Managing Director) |
Investment Manager |
m2f Investment Ltd. (DE) |
Germany |
| Friedemann, Susan (CCS Cell Culture Service 201007 Sales & Communication) |
Sales Manager / Marketing Manager |
Evotec (Group) |
Germany |
| Friedhoff, Paul (Bruker-Quantron GmbH 200609– Managing Director before Quantron GmbH Managing Director) |
Managing Director |
Bruker Corporation (Group) |
Germany |
| Friedman, Gary (Novartis 201007 Medical Director – Infectious Disease, Transplantation + Immunology) |
Chief Medical Officer (CMO) |
Novartis (Group) |
Switzerland |
| Friedman, Isaac (Abbott 201203 Head of STARLIMS business) |
President/Director/Head Business Group/Unit/Division |
Abbott (Group) |
Israel |
| Friedman, Michael (AmniSure International 201205 CEO) |
Chief Executive Officer (CEO) |
Qiagen (Group) |
United States (USA) |
| Friedman, Paul A. (Incyte 201401 non-executive Board Member before CEO) |
Board member, non-executive |
Incyte Corporation (Group) |
United States (USA) |
| Friedrich, Alex (Univ Groningen 201203 Prof + Chair Medical Microbiology and Infection Control at UMCG) |
Professor |
University of Groningen (Rijksuniversiteit Groningen) |
Netherlands |
| Friedrich, Colette (BianoScience GmbH 2010– CFO before Osram Sylvania) |
Chief Financial Officer (CFO) |
BianoScience GmbH |
Germany |
| Friedrich, Eva (SDL 201604 Field Marketing Manager DACH) |
n. a. |
SDL (Group) |
United Kingdom (GB) |
| Friedrich, Glenn A. (Kymab 201511 COO) |
Chief Operating Officer (COO) |
Kymab Group Ltd. |
United Kingdom (GB) |
| Friedrichowski, Stefan (HiperScan GmbH 200901 Managing Director Sales) |
Managing Director |
HiperScan GmbH |
Germany |
| Friedritz, Björn (Cyrano Kommunikation 201711 before BlueSens Gas Sensor GmbH 201202) |
Public Relations Manager / Investor Relations Manager |
Cyrano Kommunikation GmbH |
Germany |
| Friese, Andreas (OLS Omni Life Sciences 201901 Head of Sales) |
Sales Manager / Marketing Manager |
Omni Life Science (OLS) (Group) |
Germany |
| Friese, L. |
n. a. |
3i (Group) |
Germany |
| Friese, Manuel (Univ Hamburg 201408 Prof at UKE + Director o INIMS) |
Professor |
University of Hamburg |
Germany |
| Friesen, Robert (Ablynx 201803– CSO before ProQR Therapeutics + Janssen BioTherapeutics + MorphoSys) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Ablynx (Group) |
Belgium |
| Frisch, Jürgen (Immatics 200501– CMO before Intercell) |
Chief Medical Officer (CMO) |
Immatics (Group) |
Germany |
| Frischmuth, Thomas (Panatecs 201205– Managing Director + Greenovation 201105 Managing Director + baseclick) |
Managing Director |
Zukunftsfonds Heilbronn (Group) |
Germany |
| Fritz, Carolyn (Allylix 201411 CEO) |
Chief Executive Officer (CEO) |
Evolva (Group) |
United States (USA) |
| Fritz, Jutta (Blackfield 201307 before Kinaxo 200901– Head Business Development before Max Planck Innovation) |
Business Development Manager / Strategy Manager |
Siemens (Group) |
Germany |
| Fritz, Michaela (infineon 2003 Product Manager Flow-Thru Chips) |
Product Manager (personnel) |
Infineon (Group) |
Germany |
| Fritzsche, Steffen (Grünenthal 201611 Senior Director Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Grünenthal (Group) |
Germany |
| Frohnmeyer, Hanns (LBWW Analyst) |
Analyst (Financial / Industry) |
LBBW (Group) |
Germany |
| Fronhoff, Bernd (Axiogenesis 201603 CFO/COO) |
Chief Financial Officer (CFO) |
Evotec (Group) |
Germany |
| Frost, Peter (PeloBiotech GmbH 201202– Managing Director) |
Managing Director |
PeloBiotech GmbH |
Germany |
| Fruchterman, Todd (3M 201306 SVP RnD + CMO at 3M Health Care) |
Chief Medical Officer (CMO) |
3M (Group) |
United States (USA) |
| Fruebis, Joachim (Pfizer 201309– Senior Director before Wyeth + Boehringer + ZymoGenetics + Genset) |
Business Development Manager / Strategy Manager |
Pfizer (Group) |
United States (USA) |
| Fruhstorfer, Peter (Eppendorf 201912– Co-CEO before Head of Business Area Sample Handling) |
Chief Executive Officer (CEO) |
Eppendorf (Group) |
Germany |
| Fuchs, Jürgen (LISAvienna 201211 Cluster Manager Biotechnology + Pharma) |
Cluster Manager |
Austria (govt) |
Austria |
| Fuchs, Manfred (OHB-System 1982–200902 CEO + founder) |
Chief Executive Officer (CEO) |
Fuchs (Group) |
Germany |
| Fuchs, Marco R. (OHB-System 200902 Executive Board Director) |
Board member, executive |
Fuchs (Group) |
Germany |
| Fuchs, Markus (Knauer 201411 Sales) |
Sales Manager / Marketing Manager |
Knauer GmbH (Wissenschaftliche Gerätebau Dr. Ing. Herbert Knauer GmbH) |
Germany |
| Fuchs, Michael (Ritter GmbH 200704–) |
Sales Manager / Marketing Manager |
Ritter GmbH |
Germany |
| Fuchs, Patrick (DZ Bank) |
n. a. |
Volks- und Raiffeisenbanken (DE) (Group) |
Germany |
| Fuchslueger, Ulf (Vialis AG 201105 CEO) |
Chief Executive Officer (CEO) |
Vialis (Group) |
Switzerland |
| Fudge, Ann |
Board member, non-executive |
Novartis (Group) |
Switzerland |
| Fuenzalida, Fernando (Endress+Hauser 2012–201705 Supervisory Board Member before CFO 1998–2012) |
Supervisory Board Member |
Endress+Hauser (Group) |
Switzerland |
| Fuhge, Peter |
n. a. |
Affimed (Group) |
Germany |
| Fuhr, Günter R. (Fraunhofer 201402 Head of Fraunhofer IBMT) |
Professor |
Fraunhofer (Group) |
Germany |
| Fuhrer, David (Neopharm Group (IL) 201307 CEO + Owner) |
Chief Executive Officer (CEO) |
Neopharm (IL) (Group) |
Israel |
| Fujita, Makoto (Univ Tokyo 201906 Prof at Univ Tokyo + Institute for Molecular Science) |
Professor |
University of Tokyo |
Japan |
| Fulpius, Nicolas (Affentranger Associates 200803 Partner before Ultreia Capital Investment Director) |
Partner (venture partner) |
Affentranger Associates S.A. |
Switzerland |
| Funk, Günter (Mikromol 200503 founder) |
Company Founder |
LGC (Group) |
Germany |
| Funk, Marc (Lonza 201903–202001 CEO before COO of Pharma+Biotech division joined Lonza 1/09 LEFT 1/20) |
Chief Executive Officer (CEO) |
Lonza Group (Group) |
Switzerland |
| Furch, Marcus (Rodos BioTarget 200905 CEO) |
Chief Executive Officer (CEO) |
Rodos BioTarget GmbH |
Germany |
| Furmanski, Laura (Qiagen 2014–201711 Head of Bioinformatics Business Area RESIGNED END 2017) |
President/Director/Head Business Group/Unit/Division |
Qiagen (Group) |
Germany |
| Furst, David (Mediq Innovation Experts LLC 201707 Managing Partner befoer LifeSci + GILSC 201109) |
Managing Partner |
Mediq Innovation Experts (Group) |
Israel |
| Futch, Clarke B. (HealthCare Royalty Partners 201409 founding Managing Director) |
Managing Director |
HealthCare Royalty Partners (HC Royalty) |
United States (USA) |
| Fünfschilling, Hans (früher Roche) |
Governmental Officer (personnel) |
Switzerland (govt) |
Switzerland |
| Fürmeier, Sven (Univ Kassel 200908 Institute for Chemistry, Mass Spectrometry) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Kassel |
Germany |
| Fürstenberg-Brock (Deutsche Messe 201009 Projektleiter Biotechnica) |
Event Manager / Conference Manager |
Deutsche Messe AG |
Germany |
| Fürstner, Alois (Max Planck 1993– MPI for Coal Research Mühlheim) |
Professor |
Max Planck Society for the Advancement of Science |
|
| Fäh, Urban (Bruker Corp 201802 President of Bruker Optics) |
President/Director/Head Business Group/Unit/Division |
Bruker BioSciences (Group) |
|
| Färber, Nico (Thermo Fisher 201710 Patheon Business Development Executive Pharma Services) |
Business Development Manager / Strategy Manager |
Thermo Fisher (Group) |
Canada |
| Fäs, Stefan (BioMedPartners 201702 CFO) |
Chief Financial Officer (CFO) |
BioMedPartners (Group) |
Switzerland |
| Fässler, Christoph (Metrohm 201107 CEO) |
Chief Executive Officer (CEO) |
Metrohm (Group) |
Switzerland |
| Föll, Armin (GC biotech 200809) |
n. a. |
GC biotech (Group) |
Germany |
| Förster, Hans-Heinrich (Genolytic 201109 Managing Director) |
Managing Director |
Genolytic GmbH |
Germany |
| Förtsch, Bernd (BF Holding) |
Managing Director |
BF Holding (Group) |
Germany |
| Gaal, Lubor (Locust Walk 201807– SVP + Head of Europe before Almirall + BMS + Neuro3d + Vectron Therapeutics) |
Consultant (economic/technology) |
Locust Walk (Group) |
United Kingdom (GB) |
| Gabel, Detlef (Univ Bremen 200911 Prof Organic Chemistry + Kooperationszentrum Medizin) |
Professor |
University of Bremen |
Germany |
| Gabert, Jörg (Priontype 200602 Managing Director) |
Managing Director |
Qiagen (Group) |
Germany |
| Gabor, E. Allan (Merck (DE) 201801 MAnaging Director + Country Speaker China joined 2013 before Pfizer China) |
Regional manager |
Merck (DE) (Group) |
Germany |
| Gabriel, Raimund (MC Services 1999–201101– Founder + CEO) |
Chief Executive Officer (CEO) |
MC Services AG |
Germany |
| Gabriel, Sigmar (Germany (govt) 2014 Minister of Economic Affairs and Energy) |
Minister |
Germany (govt) |
Germany |
| Gabrielczyk, Thomas |
n. a. |
Biocom (Group) |
Germany |
| Gadicke, Ansbert (MPM Capital 201604 Bioventure Investment Manager + Co-Founder) |
Investment Manager |
MPM Capital (Group) |
United States (USA) |
| Gahlmann, Reinhold (Biofrontera 200601– Managing Director before 15y Bayer Pharma AG) |
Managing Director |
Biofrontera (Group) |
Germany |
| Gaillard, Pierre (Servier 201702 Director of Global Marketing) |
Sales Manager / Marketing Manager |
Servier (Group) |
France |
| Gaillard, Pieter J. (to-BBB 200902– CSO before CEO) |
Chief Executive Officer (CEO) |
2-BBB Medicines (Group) |
Netherlands |
| Gaissmaier, Christoph (B Braun 201307 Executive Manager) |
Board member, executive |
B. Braun (Group) |
Germany |
| Galakatos, Nicholas (Clarus Ventures 200906 Managing Director + co-founder) |
Managing Director |
Blackstone (Group) |
United States (USA) |
| Galbraith, Daniel (BioOutsource 201402 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Sartorius (Group) |
United Kingdom (GB) |
| Galbraith, Susan (AstraZeneca 201212 VP + Head Oncology Innovative Medicines Unit) |
President/Director/Head Business Group/Unit/Division |
AstraZeneca (Group) |
United Kingdom (GB) |
| Galdos, Aitor (Tecan 2003–200412 CEO left because of differences over operational management with Board) |
Chief Executive Officer (CEO) |
Tecan (Group) |
Switzerland |
| Gale, James (Signet Healthcare Partners 201507 Managing Director) |
Managing Director |
Signet Healthcare Partners (US) |
United States (USA) |
| Gales, Ann (A Gales Consulting 201709 Managing Partner) |
Managing Partner |
A Gales Consulting Ltd. |
United Kingdom (GB) |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 17 18 19 ... 68 69 70 
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px](/banner/iito-20181119-650-065-lsus-life-sciences-usa-com.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
